BIRC5 and cancer: Small-molecule suppressors of Survivin (e.g., YM155, Tetra-O-methyl nordihy-droguaiaretic acid, and LY2181308) were reported to show anti-cancer activities both in vitro and in vivo, and some of them have been applied in clinical anti-cancer therapy47–51.